1
|
Cortese-Krott MM, Fernandez BO, Santos JLT, Mergia E, Grman M, Nagy P, Kelm M, Butler A, Feelisch M. Nitrosopersulfide (SSNO(-)) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide. Redox Biol 2014; 2:234-44. [PMID: 24494198 PMCID: PMC3909780 DOI: 10.1016/j.redox.2013.12.031] [Citation(s) in RCA: 114] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2013] [Revised: 12/23/2013] [Accepted: 12/23/2013] [Indexed: 11/16/2022] Open
Abstract
Sulfide salts are known to promote the release of nitric oxide (NO) from S-nitrosothiols and potentiate their vasorelaxant activity, but much of the cross-talk between hydrogen sulfide and NO is believed to occur via functional interactions of cell regulatory elements such as phosphodiesterases. Using RFL-6 cells as an NO reporter system we sought to investigate whether sulfide can also modulate nitrosothiol-mediated soluble guanylyl cyclase (sGC) activation following direct chemical interaction. We find a U-shaped dose response relationship where low sulfide concentrations attenuate sGC stimulation by S-nitrosopenicillamine (SNAP) and cyclic GMP levels are restored at equimolar ratios. Similar results are observed when intracellular sulfide levels are raised by pre-incubation with the sulfide donor, GYY4137. The outcome of direct sulfide/nitrosothiol interactions also critically depends on molar reactant ratios and is accompanied by oxygen consumption. With sulfide in excess, a ‘yellow compound’ accumulates that is indistinguishable from the product of solid-phase transnitrosation of either hydrosulfide or hydrodisulfide and assigned to be nitrosopersulfide (perthionitrite, SSNO−; λmax 412 nm in aqueous buffers, pH 7.4; 448 nm in DMF). Time-resolved chemiluminescence and UV–visible spectroscopy analyses suggest that its generation is preceded by formation of the short-lived NO-donor, thionitrite (SNO−). In contrast to the latter, SSNO− is rather stable at physiological pH and generates both NO and polysulfides on decomposition, resulting in sustained potentiation of SNAP-induced sGC stimulation. Thus, sulfide reacts with nitrosothiols to form multiple bioactive products; SSNO− rather than SNO− may account for some of the longer-lived effects of nitrosothiols and contribute to sulfide and NO signaling. Sulfide modulates the bioactivity of nitrosothiols in a concentration-dependent manner. Nitrosopersulfide anions (SSNO−) accumulate at high sulfide/RSNO ratios. SSNO− releases NO and is surprisingly stable in the presence of reduced thiols. SSNO− is a potent activator of soluble guanylyl cyclase. SSNO− is likely to contribute to NO and hydrogen sulfide/polysulfide signaling.
Collapse
Key Words
- CysNO, S-nitrosocysteine
- DMF, dimetylformamide
- DMSO, dimethylsulfoxide
- GSNO, S-nitrosoglutathione
- HSNO
- Hydrogen sulfide
- IPN, isopentyl nitrite
- NO+, nitrosonium
- NO, nitric oxide
- Nitric oxide
- Nitroxyl
- Polysulfides
- RFL-6, rat fibroblastoid-like cell line
- SNAP, S-nitrosopenicillamine
- SNO−, thionitrite
- SSNO−, nitrosopersulfide, perthionitrite, PDE, phopsphodiesterase
- cGMP
- sGC, soluble guanylyl cyclase
Collapse
Affiliation(s)
- Miriam M Cortese-Krott
- Cardiovascular Research Laboratory, Department of Cardiology, Pneumology and Angiology, Medical Faculty, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany
| | - Bernadette O Fernandez
- Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK
| | - José L T Santos
- Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK
| | - Evanthia Mergia
- Institute for Pharmacology and Toxicology, Ruhr-University Bochum, Bochum, Germany
| | - Marian Grman
- Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Bratislava, Slovak Republic
| | - Péter Nagy
- Department of Molecular Immunology and Toxicology, National Institute of Oncology, Ráth György utca 7-9, Budapest, Hungary
| | - Malte Kelm
- Cardiovascular Research Laboratory, Department of Cardiology, Pneumology and Angiology, Medical Faculty, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany
| | - Anthony Butler
- Medical School, University of St-Andrews, St-Andrews, Fife, Scotland
| | - Martin Feelisch
- Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK
| |
Collapse
|
2
|
Diers AR, Broniowska KA, Hogg N. Nitrosative stress and redox-cycling agents synergize to cause mitochondrial dysfunction and cell death in endothelial cells. Redox Biol 2013; 1:1-7. [PMID: 24024132 PMCID: PMC3757685 DOI: 10.1016/j.redox.2012.11.003] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2012] [Revised: 11/28/2012] [Accepted: 11/30/2012] [Indexed: 02/07/2023] Open
Abstract
Nitric oxide production by the endothelium is required for normal vascular homeostasis; however, in conditions of oxidative stress, interactions of nitric oxide with reactive oxygen species (ROS) are thought to underlie endothelial dysfunction. Beyond canonical nitric oxide signaling pathways, nitric oxide production results in the post-translational modification of protein thiols, termed S-nitrosation. The potential interplay between S-nitrosation and ROS remains poorly understood and is the focus of the current study. The effects of the S-nitrosating agent S-nitrosocysteine (CysNO) in combination with redox-cycling agents was examined in bovine aortic endothelial cells (BAEC). CysNO significantly impairs mitochondrial function and depletes the NADH/NAD+ pool; however, these changes do not result in cell death. When faced with the additional stressor of a redox-cycling agent used to generate ROS, further loss of NAD+ occurs, and cellular ATP pools are depleted. Cellular S-nitrosothiols also accumulate, and cell death is triggered. These data demonstrate that CysNO sensitizes endothelial cells to redox-cycling agent-dependent mitochondrial dysfunction and cell death and identify attenuated degradation of S-nitrosothiols as one potential mechanism for the enhanced cytotoxicity.
Collapse
Key Words
- BAEC, Bovine aortic endothelial cells
- BSO, Buthioninesulphoximine
- CysNO, S-nitrosocysteine
- DMNQ, 2,3-dimethoxy-1,4-naphthoquinone
- DMSO, Dimethyl sulfoxide
- DPBS, Dulbecco’s phosphate buffered saline
- DTPA, Diethylenetriaminepentaacetic acid
- DTT, Dithiothreitol
- GAPDH, Glyceraldehyde-3-phosphate dehydrogenase
- GSHee, Glutathione Ethyl Ester
- LDH, Lactate Dehydrogenase
- Mitochondria
- N.D., Not detectable
- NAC, N-acetyl cysteine
- NOS, Nitric oxide synthase
- Nitric oxide
- OCR, Oxygen consumption rate
- ROS, Reactive oxygen species
- Reactive oxygen species
- S-nitrosation
- S-nitrosylation
- SEM, Standard error of the mean.
- Thiol
- cGMP, Cyclic guanosine monophosphate
Collapse
Affiliation(s)
- Anne R Diers
- Department of Biophysics, Redox Biology Program, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226 USA
| | | | | |
Collapse
|